Monthly Archives: November 2014

Bio-Chem recently expanded it’s services to include Pharmaceutical and Medical Device registration and regulation services in the US and Europe. The company provides GxP, Validation, Engineering, Quality Assurance, project management services & consultancy for companies from the pharmaceutical, biotechnology, medical device, cosmetics and food industries. Bio-Chem’s registration and regulation services...

The Chinese government offers a discount to exhibitors at BIOTECH CHINA for those who register through BioIsrael. BIOTECH CHINA is held once a year, combining business, commerce, matchmaking, communications, and technology. BIOTECH CHINA 2015 will include well-known companies as well as representative industry parks, hospitals and universities. There will be...

Rehovot-based NeuroDerm, which has developed a transdermal drug delivery system for the treatment of Parkinson’s disease, raised $45 million by issuing 4.5 million shares at $10 per share, giving it a company value of $164 million, after money. The amount raised could rise to $50 million, if the underwriters take...

D-Pharm Ltd (TASE: DPRM) has raised 12.8M NIS in aggregate. D-Pharm’s largest shareholder, CLAL Biotechnology (CBI), exercised all its rights to the tune of 8.7M NIS and a third of the total funds raised were from the public. D-Pharm is a clinical-stage neuroscience company focused on the development of pioneering...

Zingenix, previously known as ILIT Bio Ventures Ltd is  continuing its    development programs, focusing on gene therapy for severe orphan disorders including DMD(Ducehenne Muscular Dystrophy) ,using artificial transcription factors technologies. The company has raised a seed round of funding and has been joined by Dr. Robert Heft from Canada who has...

Compugen Ltd. (NASDAQ: CGEN) has achieved a second milestone in its cancer immunotherapy collaboration it entered last year with Bayer HealthCare (Bayer). The collaboration provides for the research, development, and commercialization of antibody-based cancer therapeutics against two novel Compugen-discovered immune checkpoint regulators. The milestone relates to the second preclinical milestone...

Researchers from Israel and Jordan are seeking a treatment for cutaneous leishmaniasis in a new project, initiated by Israeli research company Pharmaseed. The project brings together a consortium of parties from Israel, Jordan, and Switzerland for the treatment of cutaneous leishmaniasis, a variant of the parasitic disease leishmaniasis, also known...

PolyPid, which develops an antibiotic coating for bone repair, has filed with the SEC for an initial public offering on the NASDAQ in which it hopes to raise $24 million. This could leave the company with a valuation of as much as $100 million. The number of shares to be...

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), announced the United States Patent and Trademark Office has issued a patent to the Company which covers its drug candidate, CF102, in the treatment of liver regeneration and function following liver surgery. The issued patent # 8,846,635 is titled, “Method for inducing...

Micromedic Technologies which specializes in the development and commercialization of cancer diagnostic products has conducted the trial of its CellDetect for detecting cervical cancer at the Beijing Military Hospital. The company said that the tests showed that the product marks cancer cells, thereby rendering the diagnostic process more effective. It...

IonMed has received CE mark clearance for its Bioweld1™ cold plasma system for surgical incision closure. Bioweld1 is the first system in the rapidly emerging field of plasma medicine designed for use in operating room settings as an alternative to surgical staples, sutures, and sealants. The patented Bioweld1 system combines...

LapSpace Medical has completed a series of successful procedures, utilizing its inflatable laparoscopic retractor, on patients in the United States and India. The surgeries were performed by Dr. Bruce Ramshaw and Dr. Surendra Ugale, both world-renowned laparoscopic surgeons. LapSpace’s device was used to retract the intestines during laparoscopic abdominal surgery....

MediValve, Ltd., a Trendlines portfolio company, announced that it has successfully completed the first two cases of post-market clinical evaluation of its acWire Guidewire[1],[2],[3]. The acWire is intended for use in peripheral vascular and heart catheterization procedures to introduce and assist in positioning diagnostic and interventional devices. The acWire may...